Physician profile
Gregory E Hyde
NPI 1063498343
$1,507.91
in general payments reported to CMS, 2019-2025
28 companies · $244 in 2025
The $244 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $62.35 · 2021: $289 · 2022: $373 · 2023: $257 · 2024: $282 · 2025: $244.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $783.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $782.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $257.51 | 2021-2024 | Tremfya |
| Amgen INC. | $135.45 | 2021-2023 | Enbrel, Otezla |
| Ucb, INC. | $118.30 | 2020-2024 | Bimzelx, Cimzia |
| Access Pro Medical, LLC | $96.07 | 2023 | Matriderm |
| Smith+Nephew, INC. | $94.31 | 2021-2025 | Grafix Pl, Collagenase Santyl |
| Glaxosmithkline, LLC. | $93.55 | 2021-2025 | Nucala |
| Kerecis Limited | $61.70 | 2023-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Integra Lifesciences Corporation | $57.24 | 2024 | Inspira Air, Acclarent Aera, Relieva Spinplus Nav |
| Mallinckrodt Hospital Products INC. | $54.44 | 2022-2024 | Acthar |
| Lundbeck LLC | $52.45 | 2020-2021 | |
| Convatec INC. | $43.92 | 2024 | |
| Lilly USA, LLC | $41.21 | 2020-2021 | |
| Davol INC. | $40.01 | 2025 | Arista |
| Stryker Corporation | $39.51 | 2021-2022 | |
| Eisai INC. | $38.66 | 2021 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $36.55 | 2025 | Tapestry |
| Bioventus LLC | $34.20 | 2023-2025 | Exogen Ultrasound Bone Healing System, Gelsyn-3 |
| Horizon Therapeutics Plc | $28.06 | 2021 | |
| Hologic Sales and Service, LLC | $23.39 | 2024 | Coolseal Generator |
| Acclarent, INC | $21.63 | 2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $20.53 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $19.91 | 2023 | Exparel, Zilretta, Iovera |
| Astrazeneca Pharmaceuticals Lp | $18.99 | 2022 | |
| Phathom Pharmaceuticals, INC. | $17.73 | 2024 | Voquezna |
| Polynovo North America LLC | $16.86 | 2024 | Novosorb Btm |
| Organogenesis INC. | $15.87 | 2025 | Puraply Wound Matrix |
| Neurelis, INC. | $15.55 | 2021 | |
| Alexion Pharmaceuticals, INC. | $14.31 | 2024 | Koselugo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Hyde listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.